Anti-RRM2 monoclonal antibody

Pre-made anti-RRM2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RRM2/RRM2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0011-Ab-1/ GM-Tg-hg-IP0011-Ab-2Anti-Human RRM2 monoclonal antibodyHuman
GM-Tg-rg-IP0011-Ab-1/ GM-Tg-rg-IP0011-Ab-2Anti-Rat RRM2 monoclonal antibodyRat
GM-Tg-mg-IP0011-Ab-1/ GM-Tg-mg-IP0011-Ab-2Anti-Mouse RRM2 monoclonal antibodyMouse
GM-Tg-cynog-IP0011-Ab-1/ GM-Tg-cynog-IP0011-Ab-2Anti-Cynomolgus/ Rhesus macaque RRM2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0011-Ab-1/ GM-Tg-felg-IP0011-Ab-2Anti-Feline RRM2 monoclonal antibodyFeline
GM-Tg-cang-IP0011-Ab-1/ GM-Tg-cang-IP0011-Ab-2Anti-Canine RRM2 monoclonal antibodyCanine
GM-Tg-bovg-IP0011-Ab-1/ GM-Tg-bovg-IP0011-Ab-2Anti-Bovine RRM2 monoclonal antibodyBovine
GM-Tg-equg-IP0011-Ab-1/ GM-Tg-equg-IP0011-Ab-2Anti-Equine RRM2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0011-Ab-1/ GM-Tg-hg-IP0011-Ab-2; GM-Tg-rg-IP0011-Ab-1/ GM-Tg-rg-IP0011-Ab-2;
GM-Tg-mg-IP0011-Ab-1/ GM-Tg-mg-IP0011-Ab-2; GM-Tg-cynog-IP0011-Ab-1/ GM-Tg-cynog-IP0011-Ab-2;
GM-Tg-felg-IP0011-Ab-1/ GM-Tg-felg-IP0011-Ab-2; GM-Tg-cang-IP0011-Ab-1/ GM-Tg-cang-IP0011-Ab-2;
GM-Tg-bovg-IP0011-Ab-1/ GM-Tg-bovg-IP0011-Ab-2; GM-Tg-equg-IP0011-Ab-1/ GM-Tg-equg-IP0011-Ab-2
Products NameAnti-RRM2 monoclonal antibody
Formatmab
Target NameRRM2
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RRM2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0011-Ag-1Recombinant multi-species RIR2/ RRM2/ R2 protein
    ORF Viral VectorpGMLPm002610mouse Rrm2 Lentivirus plasmid
    ORF Viral VectorpGMLPm004439mouse Rrm2 Lentivirus plasmid
    ORF Viral VectorvGMLPm002610mouse Rrm2 Lentivirus particle
    ORF Viral VectorvGMLPm004439mouse Rrm2 Lentivirus particle


    Target information

    Target IDGM-IP0011
    Target NameRRM2
    Gene ID6241,20135,362720,703138,482963,101087987,508167,100072410
    Gene Symbol and SynonymsC2orf48,R2,RR2,RR2M,RRM2
    Uniprot AccessionP31350,Q4KLN6
    Uniprot Entry NameRIR2_HUMAN,RIR2_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseBreast Cancer
    Gene EnsemblENSG00000171848
    Target ClassificationN/A

    The target: RRM2, gene name: RRM2, also named as R2, RR2, RR2M. This gene encodes one of two non-identical subunits for ribonucleotide reductase. This reductase catalyzes the formation of deoxyribonucleotides from ribonucleotides. Synthesis of the encoded protein (M2) is regulated in a cell-cycle dependent fashion. Transcription from this gene can initiate from alternative promoters, which results in two isoforms that differ in the lengths of their N-termini. Related pseudogenes have been identified on chromosomes 1 and X. [provided by RefSeq, Sep 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.